Replicon Technologies, Inc. Targets Central Nervous System Cancers Using Poliovirus Tumor-Killing RNA Technology
(Business Wire)Replicon Technologies, Inc., a biopharmaceutical company focused on developing therapeutic applications for replicons, has announced that it is targeting its technology for the growing population of patients who have developed brain and spinal cord cancers and metastases.- Jun 12 10:33 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/bw/010612/2367.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines